Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001971522-25-000003
Filing Date
2025-03-14
Accepted
2025-03-14 19:32:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2901
  Complete submission text file 0001971522-25-000003.txt   4362
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Subject) CIK: 0001723128 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38485 | Film No.: 25741923
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TARSADIA INVESTMENTS 520 NEWPORT CENTER DRIVE, 21ST FLOOR NEWPORT BEACH CA 92660
Business Address
Patel Tushar Bhikhubhai (Reporting) CIK: 0001745375 (see all company filings)

Type: 144